Search

everythinglearnresearchcommunity

for

Search:↓

A woman with Cushing's syndrome improved after surgery to remove a tumor causing the condition.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

Pancreatic cancer pain management is inadequate due to the disease's severity and limited effectiveness of treatments.

Epinephrine does not significantly affect the severity of hair loss after surgery.

Hair transplant is effective for treating hair loss caused by radiation and improves patients' quality of life.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Better awareness of chemotherapy's side effects improves self-care.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Clipping is the best method to prepare rats for studying hair loss from chemotherapy because it causes less skin damage and effectively gets hair to the right growth phase.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.